RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C

被引：0
|
作者：
Turnes, Juan [1 ]
Garcia-Herola, Antonio [2 ]
Morillo, Ramon [3 ]
Mendez, Marinela [4 ]
Rueda, Magdalena [4 ]
Hernandez, Candido [5 ]
Sicras-Mainar, Antoni [6 ]
机构：
[1] CHU, Gastroenterol & Hepatol Dept, Pontevedra, Spain
[2] Hosp Marina Baixa de Villajoyosa, Digest Med Dept, Alicante, Spain
[3] AGS Sur Sevilla, Hosp Valme, Hosp Pharm, Seville, Spain
[4] Gilead Sci SL, Med Affairs, Madrid, Spain
[5] Gilead Sci Europe Ltd, Global Med Affairs, London, England
[6] Atrys Hlth, Hlth Econ & Outcomes Res, Barcelona, Spain
来源：
GUT | 2022年 / 71卷
关键词：
D O I：
10.1136/gutjnl-2022-IDDF.125
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2022-A
引用
收藏
页码：A97 / A98
页数：2
相关论文
共 50 条
  • [31] Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals
    Ozaras, Resat
    Mete, Bilgul
    Tabak, Fehmi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (04) : 605 - 605
  • [32] Targeting Hepatitis C With Direct-Acting Antivirals
    Pennell, Laurie
    LaPreze, Jennifer
    US PHARMACIST, 2023, 48 (02) : HS6 - +
  • [33] Direct-acting antivirals for chronic hepatitis C
    Jakobsen, Janus C.
    Nielsen, Emil Eik
    Feinberg, Joshua
    Katakam, Kiran Kumar
    Fobian, Kristina
    Hauser, Goran
    Poropat, Goran
    Djurisic, Snezana
    Weiss, Karl Heinz
    Bjelakovic, Milica
    Bjelakovic, Goran
    Klingenberg, Sarah Louise
    Liu, Jian Ping
    Nikolova, Dimitrinka
    Koretz, Ronald L.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [34] Update on hepatitis C: Direct-acting antivirals
    Leon L Seifert
    Ryan B Perumpail
    Aijaz Ahmed
    World Journal of Hepatology, 2015, (28) : 2829 - 2833
  • [35] Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C
    Neokosmidis, Georgios
    Protopapas, Adonis A.
    Stogiannou, Dimitrios
    Filippidis, Athanasios
    Tziomalos, Konstantinos
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (01): : 58 - 66
  • [36] Direct-acting antivirals for chronic hepatitis C
    Jakobsen, Janus C.
    Nielsen, Emil Eik
    Feinberg, Joshua
    Katakam, Kiran Kumar
    Fobian, Kristina
    Hauser, Goran
    Poropat, Goran
    Djurisic, Snezana
    Weiss, Karl Heinz
    Bjelakovic, Milica
    Bjelakovic, Goran
    Klingenberg, Sarah Louise
    Liu, Jian Ping
    Nikolova, Dimitrinka
    Koretz, Ronald L.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [37] Update on hepatitis C: Direct-acting antivirals
    Seifert, Leon L.
    Perumpail, Ryan B.
    Ahmed, Aijaz
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (28) : 2829 - 2833
  • [38] Direct-acting antivirals: the endgame for hepatitis C?
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Colombo, Massimo
    Aghemo, Alessio
    CURRENT OPINION IN VIROLOGY, 2017, 24 : 31 - 37
  • [39] EFFECTIVENESS AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN PSYCHIATRIC HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, Luis
    Bobadilla-Perez, Eva
    Carlos Yanez-Rubal, Juan
    Prieto-Perez, Andrea
    Cid-Silva, Purificacion
    Rodriguez-Sotelo, Alejandro
    Gimenez-Arufe, Victor
    Quiroga-Fernandez, Candela
    Isabel Sanclaudio-Luhia, Ana
    Novo-Ponte, Ana
    Mena-De-Cea, Alvaro
    Martin-Herranz, Isabel
    Castro-Iglesias, Angeles
    HEPATOLOGY, 2019, 70 : 966A - 966A
  • [40] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
    Chinchilla-Lopez, Paulina
    Qi, Xingshun
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
12345